GlobeNewswire: Globus Medical Contains the last 10 of 132 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T12:32:15ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2024/02/20/2832302/0/en/Globus-Medical-Reports-Fourth-Quarter-and-Full-Year-2023-Results.html?f=22&fvtc=4&fvtv=28586Globus Medical Reports Fourth Quarter and Full Year 2023 Results2024-02-20T21:15:00Z<![CDATA[AUDUBON, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the fourth quarter and year ended December 31, 2023.]]>https://www.globenewswire.com/news-release/2024/02/13/2828706/0/en/Globus-Medical-Schedules-Fourth-Quarter-and-Full-Year-2023-Earnings-Release-and-Conference-Call.html?f=22&fvtc=4&fvtv=28586Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call2024-02-13T22:17:08Z<![CDATA[AUDUBON, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2023 after the market close on Tuesday, February 20, 2024. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.]]>https://www.globenewswire.com/news-release/2024/02/05/2823880/0/en/Globus-Medical-promotes-Keith-Pfeil-to-Chief-Operating-Officer-and-Chief-Financial-Officer.html?f=22&fvtc=4&fvtv=28586Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer2024-02-05T21:30:00Z<![CDATA[Pfeil takes on expanded responsibilities while Globus fuels its next phase of growth Pfeil takes on expanded responsibilities while Globus fuels its next phase of growth]]>Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial OfficerChief Financial Officer and Chief Operating Officerhttps://www.globenewswire.com/news-release/2024/01/10/2807524/0/en/Globus-Medical-Reports-Preliminary-Record-Fourth-Quarter-and-Full-Year-Sales-Results.html?f=22&fvtc=4&fvtv=28586Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results2024-01-10T21:30:00Z<![CDATA[AUDUBON, Pa., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year ending December 31, 2023. The company anticipates fourth quarter 2023 sales of approximately $615.5 million, an increase of 124.2 percent over the fourth quarter 2022 on an as-reported basis. Full year 2023 sales are expected to be approximately $1.567 billion, an increase of 53.2 percent over the prior year on an as-reported basis.]]>https://www.globenewswire.com/news-release/2023/11/07/2775658/0/en/Globus-Medical-Reports-Third-Quarter-2023-Results.html?f=22&fvtc=4&fvtv=28586Globus Medical Reports Third Quarter 2023 Results2023-11-07T21:15:00Z<![CDATA[AUDUBON, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2023. The merger with NuVasive, Inc. was completed on September 1, 2023 and results presented within include NuVasive, Inc. results from that closing date.]]>https://www.globenewswire.com/news-release/2023/10/24/2766064/0/en/Globus-Medical-Schedules-Third-Quarter-Earnings-Release-and-Conference-Call.html?f=22&fvtc=4&fvtv=28586Globus Medical Schedules Third Quarter Earnings Release and Conference Call2023-10-24T20:30:00Z<![CDATA[AUDUBON, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended September 30, 2023 after the market close on Tuesday, November 7, 2023. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.]]>https://www.globenewswire.com/news-release/2023/10/24/2765450/0/en/Five-Year-Study-Outcomes-of-the-NuVasive-Simplify-Cervical-Disc-were-Presented-at-the-North-American-Spine-Society-38th-Annual-Meeting.html?f=22&fvtc=4&fvtv=28586Five-Year Study Outcomes of the NuVasive Simplify Cervical Disc were Presented at the North American Spine Society 38th Annual Meeting2023-10-24T11:00:00Z<![CDATA[AUDUBON, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, presented five-year outcomes from the NuVasive Simplify Cervical Disc study at the North American Spine Society (NASS) 38th Annual Meeting. The study demonstrates positive, long-term clinical outcomes, a high rate of overall composite success at 60 months, and statistical superiority to anterior cervical discectomy fusion (ACDF) procedural outcomes.]]>https://www.globenewswire.com/news-release/2023/10/10/2757318/0/en/Twenty-Years-of-the-NuVasive-XLIF-Procedure-Celebrated-at-the-Society-for-Minimally-Invasive-Spine-Surgery-2023-Annual-Forum.html?f=22&fvtc=4&fvtv=28586Twenty Years of the NuVasive XLIF Procedure Celebrated at the Society for Minimally Invasive Spine Surgery 2023 Annual Forum2023-10-10T11:00:00Z<![CDATA[AUDUBON, Pa., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, celebrated twenty years of the NuVasive XLIF procedure at the Society for Minimally Invasive Spine Surgery (SMISS) ’23 Annual Forum.]]>https://www.globenewswire.com/news-release/2023/09/27/2750230/0/en/Globus-Medical-and-NuVasive-to-Sponsor-and-Participate-at-EUROSPINE-2023.html?f=22&fvtc=4&fvtv=28586Globus Medical and NuVasive to Sponsor and Participate at EUROSPINE 20232023-09-27T11:00:00Z<![CDATA[AUDUBON, Pa., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it will continue its partnership with EUROSPINE as a silver sponsor and will attend EUROSPINE 2023 held October 4 to 6 in Frankfurt.]]>https://www.globenewswire.com/news-release/2023/09/07/2739177/0/en/NuVasive-Specialized-Orthopedics-Launches-Precice-Bone-Transport-in-International-Markets.html?f=22&fvtc=4&fvtv=28586NuVasive Specialized Orthopedics Launches Precice Bone Transport in International Markets2023-09-07T11:00:00Z<![CDATA[AUDUBON, Pa., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the commercial launch of NuVasive Specialized Orthopedics’ (NSO) Precice Bone Transport system in targeted regions. The latest addition to the less invasive NSO portfolio is now CE-marked and approved and available in select markets.]]>